Santen Pharmaceutical Co Ltd (OTCPK:SNPHY)
$ 9.928 -1.002 (-9.17%) Market Cap: 3.75 Bil Enterprise Value: 3.20 Bil PE Ratio: 22.08 PB Ratio: 2.01 GF Score: 80/100

Santen Pharmaceutical Co Ltd at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 03:00PM GMT
Release Date Price: $16.21 (+0.25%)
Seiji Wakao
JPMorgan Chase & Co, Research Division - VP

Good morning, everyone. Welcome to the JPMorgan Healthcare Conference. I'm Seiji Wakao, Japan pharma analyst in JPMorgan. And it's my pleasure to introduce Shigeo Taniuchi, CEO of Santen, and welcome him to the conference.

The presentation will be followed directly by Q&A. (Operator Instructions) And for Q&A session, Satoshi Suzuki, Senior Corporate Officer, Head of Corporate Development Division will join.

With that, let me turn it over to Taniuchi-san. Please go ahead, Taniuchi-san.

Shigeo Taniuchi
Santen Pharmaceutical Co., Ltd. - President, CEO & Representative Director

(foreign language) Hello, everyone. Thank you very much for joining the session with us, Santen. So I'm Shigeo Taniuchi, CEO of Santen. I'm very happy to make a presentation today to you to update our strategy and also talk about our future outlook.

I think we are in a tight rope, Slide 1. So last year, 2020 was, of course, one of the most memorable and difficult year for global community.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot